An Open-Label Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn’s Disease (Holiday)
Recruiting
18 years - 64 years
All
1 Location
Brief description of study
You are being asked to take part in this research study because you have Crohn’s disease and the medical treatments you have tried have not brought you to full remission (clinically and physically symptom-free).
Detailed description of study
If you agree to take part, your participation will last for 6-7 months and will involve 5 study visits each of approximately 60 minutes in length and 3 telephone calls each of approximately 30 minutes in length.
You might be eligible to participate in this trial if:
1. You have Crohn’s Disease
2. You are between the ages of 18-64
3. You have tried multiple therapies with NO relief
4. You failed 8 weeks of:
• Azathioprine
• 6-mercaptopureine
• Methotrexate
• Adalimumab
• Certolizumab
• Golimumab
• Infliximab
• Natalizumab OR
• Vedolizumab
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Inflammatory Bowel Diseases, crohns
-
Age: 18 years - 64 years
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 823635
Find a site
,
Your Information has been sent successfully.
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Message For Non Enrolling By Invitation Trial
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or